Universal BCMA-targeted LUCAR-B68 Cells in Patients With Relapsed/Refractory Multiple Myeloma
Clinical trial NCT05498545 · TERMINATED
Trial details
- NCT number
- NCT05498545
- Sponsor
- Second Affiliated Hospital of Xi'an Jiaotong University
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-24
- Primary completion
- 2025-05-30
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.